- Generic name
- Ondansetron
- Strength
- 4 mg
- Dosage form
- Tablet
- Manufactured by
- Biopharma Ltd.
Danston-4 Tablet
About Danston-4 Tablet
Danston-4 4 mg tablet is a medicine made by Biopharma Ltd. Danston-4 tablet is used to prevent nausea and vomiting that can occur with cancer chemotherapy and radiotherapy.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Danston-4 Tablet?
Danston-4 4 mg tablet is a medicine made by Biopharma Ltd. It does not treat the underlying cause of nausea, and it is not a general stomach medicine. It is used to prevent and treat nausea and vomiting linked to cancer chemotherapy, radiotherapy, and surgery. The dose and how often it is given will be decided by the doctor based on the patient's condition.
Uses of Danston-4
Danston-4 tablet is used to prevent nausea and vomiting that can occur with cancer chemotherapy and radiotherapy. The tablet is given by a healthcare professional. Danston-4 tablet is used to help prevent nausea and vomiting caused by emetogenic cancer chemotherapy, including repeat courses of treatment. The doctor decides if this medicine is suitable for a particular patient.
How to use Danston-4
If a dose is missed, ask the doctor or pharmacist what to do rather than guessing. Danston-4 is taken by mouth. Swallow the tablet with water. Swallow the tablet as advised. If you miss a dose, ask your doctor or pharmacist for advice. The doctor decides the dose and course of treatment.
Side effects of Danston-4
Some people may notice side effects after receiving Danston-4. Tell the doctor or nurse promptly if you feel unwell after the tablet so the cause can be checked. Rare reports include allergic-type reactions, breathing difficulty, fast heartbeat, chest pain and low potassium. Tell your doctor if you notice any side effect, especially one that is severe or does not go away.
Safety and precautions
It is not a medicine that speeds up stomach or bowel movement and should not replace other treatments your doctor advises. Danston-4 should not be used by anyone who has had an allergic reaction to Ondansetron or any of its ingredients. This medicine can hide signs of bowel problems after abdominal surgery, so your doctor should know your full medical history. Your doctor will decide if it is right for you.
Frequently asked questions
What does Danston-4 treat?
Danston-4 tablet is used to prevent nausea and vomiting that can occur with cancer chemotherapy and radiotherapy. The tablet is given by a healthcare professional.
How do I use Danston-4 correctly?
If a dose is missed, ask the doctor or pharmacist what to do rather than guessing. Danston-4 is taken by mouth.
Can Danston-4 cause side effects?
Some people may notice side effects after receiving Danston-4. Tell the doctor or nurse promptly if you feel unwell after the tablet so the cause can be checked.
Who should be careful with Danston-4?
It is not a medicine that speeds up stomach or bowel movement and should not replace other treatments your doctor advises. Danston-4 should not be used by anyone who has had an allergic reaction to Ondansetron or any of its ingredients.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.